- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nymox Pharmaceutical Corp (NYMXF)
Nymox Pharmaceutical Corp stock price live, this page displays OTC NYMXF stock exchange data. View the NYMXF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nymox Pharmaceutical Corp real time stock price chart below.
What Is the Nymox Pharmaceutical Corp Stock Price Today?
The Nymox Pharmaceutical Corp stock price today is 0.0200.
What Is the Stock Symbol for Nymox Pharmaceutical Corp?
The stock symbol for Nymox Pharmaceutical Corp is "NYMXF."
What Stock Exchange Does Nymox Pharmaceutical Corp Trade On?
Nymox Pharmaceutical Corp is listed and trades on the OTC Markets stock exchange.
Is Nymox Pharmaceutical Corp a Good Stock to Buy?
Determining whether Nymox Pharmaceutical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NYMXF quote. (ISIN: BSP733981026)
What Is the Nymox Pharmaceutical Corp Stock Price Today?
The Nymox Pharmaceutical Corp stock price today is 0.0200.
What Is the Stock Symbol for Nymox Pharmaceutical Corp?
The stock symbol for Nymox Pharmaceutical Corp is "NYMXF."
What Stock Exchange Does Nymox Pharmaceutical Corp Trade On?
Nymox Pharmaceutical Corp is listed and trades on the OTC Markets stock exchange.
Is Nymox Pharmaceutical Corp a Good Stock to Buy?
Determining whether Nymox Pharmaceutical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NYMXF quote. (ISIN: BSP733981026)
OTC Markets
Currency in USD
0.0200
0.0000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0200
0.0200
52 wk Range
0.0002
0.1999
NYMXF is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.02000.0200
52 wk Range
0.00020.1999
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NYMXF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Earnings
Latest Release
Jun 03, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
Compare NYMXF to Peers and Sector
Metrics to compare | NYMXF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNYMXFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −1.6x | −0.4x | |
PEG Ratio | 0.12 | −0.06 | 0.00 | |
Price/Book | - | 1.6x | 2.6x | |
Price / LTM Sales | - | 0.9x | 3.0x | |
Upside (Analyst Target) | - | 147.9% | 54.5% | |
Fair Value Upside | Unlock | 11.1% | 7.0% | Unlock |
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a simple, cost-effective test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer’s disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Nymox Pharmaceutical (NYMXF) Stock Price Today?
The Nymox Pharmaceutical stock price today is 0.0200 USD.
What Stock Exchange Does Nymox Pharmaceutical Trade On?
Nymox Pharmaceutical is listed and trades on the OTC Markets.
What Is the Stock Symbol for Nymox Pharmaceutical?
The stock symbol for Nymox Pharmaceutical is "NYMXF."
What Is the Nymox Pharmaceutical Market Cap?
As of today, Nymox Pharmaceutical market cap is 2.1000M USD.
What Is Nymox Pharmaceutical's Earnings Per Share (TTM)?
The Nymox Pharmaceutical EPS (TTM) is -0.0500.
From a Technical Analysis Perspective, Is NYMXF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Nymox Pharmaceutical Stock Split?
Nymox Pharmaceutical has split 0 times.
How Many Employees Does Nymox Pharmaceutical Have?
Nymox Pharmaceutical has 16 employees.
What is the current trading status of Nymox Pharmaceutical (NYMXF)?
As of Sep 19, 2026, Nymox Pharmaceutical (NYMXF) is trading at a price of 0.0200 USD, with a previous close of 0.0200 USD. The stock has fluctuated within a day range of 0.0200 USD to 0.0200 USD, while its 52-week range spans from 0.0002 USD to 0.1999 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.